⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KAPA News
Kairos Pharma, Ltd.
Kairos Pharma, Ltd.宣布簽署投資條件書，戰略性收購Celyn Therapeutics旗下兩份臨床腫瘤資產
businesswire.com
KAPA
Kairos Pharma, Ltd.宣布签署战略资产收购条款清单 拟收购Celyn Therapeutics两项临床阶段肿瘤资产
businesswire.com
KAPA
Kairos Pharma, Ltd. annuncia la sigla di un memorandum d'intesa per l'acquisizione di due asset clinici oncologici strategici da Celyn Therapeutics
businesswire.com
KAPA
Kairos Pharma, Ltd. kondigt ondertekening aan van term sheet voor strategische overname van twee klinische oncologie-activa van Celyn Therapeutics
businesswire.com
KAPA
Kairos Pharma, Ltd. firma un acuerdo estratégico para adquirir dos prometedores activos clínicos oncológicos de Celyn Therapeutics
businesswire.com
KAPA
Kairos Pharma, Ltd. anuncia assinatura de termo de compromisso para a aquisição estratégica de dois ativos oncológicos clínicos da Celyn Therapeutics
businesswire.com
KAPA
Kairos Pharma, Ltd. annonce la signature d'une feuille de modalités visant l'acquisition stratégique de deux actifs en oncologie clinique de Celyn Therapeutics
businesswire.com
KAPA
Kairos Pharma, Ltd. gibt Unterzeichnung einer Grundsatzvereinbarung über den strategischen Erwerb von zwei klinischen Onkologie-Assets von Celyn Therapeutics bekannt
businesswire.com
KAPA
Form 8-K
sec.gov
KAPA
Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets from Celyn Therapeutics
businesswire.com
KAPA